What does the current environment mean for the long-term appeal of private markets? In this article, Titanbay considers recent research into investor sentiment towards private equity and more.
What does the current environment mean for the long-term appeal of private markets? In this article, Titanbay considers recent research into investor sentiment towards private equity and more.
In this week’s FB Roundup, Teddy Sagi launches a £1.5 billion sale of London’s Camden Market; Bill Gates vows to drop off the world's richest list; and Zimbabwe’s richest man Strive Masiyiwa is raising $500 million for his digital business expansion.
In this week’s FB Roundup, Teddy Sagi launches a £1.5 billion sale of London’s Camden Market; Bill Gates vows to drop off the world's richest list; and Zimbabwe’s richest man Strive Masiyiwa is raising $500 million for his digital business expansion.
It is hard to overstate how far free and unlimited central bank liquidity has rewired the financial system. As central bankers extract themselves from the monetary rabbit hole they have burrowed their way into, the damage to traditional portfolios is likely to be considerable, says Jamie Dannhauser of Ruffer LLP.
It is hard to overstate how far free and unlimited central bank liquidity has rewired the financial system. As central bankers extract themselves from the monetary rabbit hole they have burrowed their way into, the damage to traditional portfolios is likely to be considerable, says Jamie Dannhauser of Ruffer LLP.
Silicon Valley Bank and Campden Wealth’s report, Family Offices Investing in Venture Capital, July 2022, finds that family office participation in venture continues to grow despite macro concerns.
Silicon Valley Bank and Campden Wealth’s report, Family Offices Investing in Venture Capital, July 2022, finds that family office participation in venture continues to grow despite macro concerns.
Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum on July 12 and 13.
Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.
Editor's Pick